2014
DOI: 10.1016/j.echo.2014.04.020
|View full text |Cite
|
Sign up to set email alerts
|

An Observational Study of the Occurrence of Serious Adverse Reactions among Patients Who Receive Optison in Routine Medical Practice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 18 publications
0
3
0
Order By: Relevance
“…No further treatment is necessary, pain should resolve spontaneously within a few minutes. In case of further need of UCA in these patients, an alternative such as SonoVue or Optison may be used [48].…”
Section: Adverse Eventsmentioning
confidence: 99%
“…No further treatment is necessary, pain should resolve spontaneously within a few minutes. In case of further need of UCA in these patients, an alternative such as SonoVue or Optison may be used [48].…”
Section: Adverse Eventsmentioning
confidence: 99%
“…Optison ® under US application has been used for temporary disruption of the BBB, though side effects like vasoconstriction and hemorrhages might occur with sub-optimal US setting ( Hynynen et al, 2001 ; Raymond et al, 2007 ). For echocardiography, application of Optison ® was found to be generally safe in patients with different cardiologic problems, and potential induction of myocardial necrosis was ruled out ( Borges et al, 2002 ; Wei et al, 2014 ). Nonetheless, in patients with an unstable cardiopulmonary status or an acute myocardial infarction, application is contraindicated ( Dolan et al, 2009 ).…”
Section: Diagnosticsmentioning
confidence: 99%
“…Adverse effects though are rare and generally mild and temporary, and unlike other imaging modalities, USCA have been safely applied to patients with renal diseases, kidney failure or a generally very bad health condition without an increase in side effects. In at least three cases, however, patients died after SonoVue ® injection, but it is uncertain if the CA injections caused the events ( van der Wouw et al, 2000 ; ter Haar, 2009 ; Wei et al, 2014 ).…”
Section: Biodistribution and Degradationmentioning
confidence: 99%